Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Martin Watterson

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 3, 2014
Target engagement analysis and link to pharmacodynamic endpoint for a novel class of CNS-penetrant and efficacious p38α MAPK inhibitorsAdam D Bachstetter, D Martin Watterson, Linda J Van Eldik
Current Topics in Medicinal Chemistry|September 3, 2010
Application of NMR spectroscopy in medicinal chemistry and drug discoveryBrian Ross, Thao Tran, Pratip Bhattacharya, et al.
Neurobiology of Aging|July 15, 2018
An isoform-selective p38α mitogen-activated protein kinase inhibitor rescues early entorhinal cortex dysfunctions in a mouse model of Alzheimer's diseaseGrazia Rutigliano, Martina Stazi, Ottavio Arancio, et al.
Biochemistry|November 8, 2006
Death-associated protein kinase phosphorylates mammalian ribosomal protein S6 and reduces protein synthesisAndrew M Schumacher, Anastasia V Velentza, D Martin Watterson, et al.
Journal of Neuroinflammation|June 22, 2005
Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloidJeffrey M Craft, D Martin Watterson, Emmet Hirsch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Drug DevelopmentLinda Jo Van Eldik, Saktimayee M Roy, Ottavio Arancio, et al.
Glia|April 6, 2005
Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human beta-amyloidJeffrey M Craft, D Martin Watterson, Alexander Marks, et al.
Biochimica Et Biophysica Acta|November 26, 2002
DAPK catalytic activity in the hippocampus increases during the recovery phase in an animal model of brain hypoxic-ischemic injuryAndrew M Schumacher, Anastasia V Velentza, D Martin Watterson, et al.
Journal of Neurotrauma|May 22, 2010
Minozac treatment prevents increased seizure susceptibility in a mouse "two-hit" model of closed skull traumatic brain injury and electroconvulsive shock-induced seizuresMaryAnn Chrzaszcz, Charu Venkatesan, Tina Dragisic, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 24, 2015
Closed head injury in an age-related Alzheimer mouse model leads to an altered neuroinflammatory response and persistent cognitive impairmentScott J Webster, Linda J Van Eldik, D Martin Watterson, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 3, 2014
Target engagement analysis and link to pharmacodynamic endpoint for a novel class of CNS-penetrant and efficacious p38α MAPK inhibitorsAdam D Bachstetter, D Martin Watterson, Linda J Van Eldik
Current Topics in Medicinal Chemistry|September 3, 2010
Application of NMR spectroscopy in medicinal chemistry and drug discoveryBrian Ross, Thao Tran, Pratip Bhattacharya, et al.
Neurobiology of Aging|July 15, 2018
An isoform-selective p38α mitogen-activated protein kinase inhibitor rescues early entorhinal cortex dysfunctions in a mouse model of Alzheimer's diseaseGrazia Rutigliano, Martina Stazi, Ottavio Arancio, et al.
Biochemistry|November 8, 2006
Death-associated protein kinase phosphorylates mammalian ribosomal protein S6 and reduces protein synthesisAndrew M Schumacher, Anastasia V Velentza, D Martin Watterson, et al.
Journal of Neuroinflammation|June 22, 2005
Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloidJeffrey M Craft, D Martin Watterson, Emmet Hirsch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Drug DevelopmentLinda Jo Van Eldik, Saktimayee M Roy, Ottavio Arancio, et al.
Glia|April 6, 2005
Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human beta-amyloidJeffrey M Craft, D Martin Watterson, Alexander Marks, et al.
Biochimica Et Biophysica Acta|November 26, 2002
DAPK catalytic activity in the hippocampus increases during the recovery phase in an animal model of brain hypoxic-ischemic injuryAndrew M Schumacher, Anastasia V Velentza, D Martin Watterson, et al.
Journal of Neurotrauma|May 22, 2010
Minozac treatment prevents increased seizure susceptibility in a mouse "two-hit" model of closed skull traumatic brain injury and electroconvulsive shock-induced seizuresMaryAnn Chrzaszcz, Charu Venkatesan, Tina Dragisic, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 24, 2015
Closed head injury in an age-related Alzheimer mouse model leads to an altered neuroinflammatory response and persistent cognitive impairmentScott J Webster, Linda J Van Eldik, D Martin Watterson, et al.
Pageof 8